1. Home
  2. NGS vs EOLS Comparison

NGS vs EOLS Comparison

Compare NGS & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Gas Services Group Inc.

NGS

Natural Gas Services Group Inc.

HOLD

Current Price

$37.97

Market Cap

473.6M

Sector

Energy

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

N/A

Current Price

$8.16

Market Cap

550.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NGS
EOLS
Founded
1998
2012
Country
United States
United States
Employees
259
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
473.6M
550.9M
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
NGS
EOLS
Price
$37.97
$8.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$40.67
$15.50
AVG Volume (30 Days)
108.6K
933.3K
Earning Date
05-11-2026
05-04-2026
Dividend Yield
1.08%
N/A
EPS Growth
14.60
1.23
EPS
0.83
N/A
Revenue
$172,315,000.00
$297,176,000.00
Revenue This Year
$15.05
$13.27
Revenue Next Year
$9.52
$17.62
P/E Ratio
$44.27
N/A
Revenue Growth
9.94
11.61
52 Week Low
$24.26
$3.86
52 Week High
$44.61
$8.43

Technical Indicators

Market Signals
Indicator
NGS
EOLS
Relative Strength Index (RSI) 50.01 71.95
Support Level $36.66 $6.44
Resistance Level $40.34 N/A
Average True Range (ATR) 1.59 0.40
MACD 0.23 0.23
Stochastic Oscillator 97.72 88.38

Price Performance

Historical Comparison
NGS
EOLS

About NGS Natural Gas Services Group Inc.

Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. It operates in one reporting segment. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: